Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other Immunodeficiencies
- 27 March 1986
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 314 (13) , 801-805
- https://doi.org/10.1056/nejm198603273141301
Abstract
The drug 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) was used to treat serious cytomegalovirus infections in 26 patients with underlying immunodeficiency (including 22 with the acquired immunodeficiency syndrome).This publication has 23 references indexed in Scilit:
- Cytomegalovirus ColitisGastroenterology, 1985
- Ophthalmic Involvement in Acquired Immunodeficiency SyndromeOphthalmology, 1984
- Opportunistic Infection Complicating Acquired Immune Deficiency SyndromeMedicine, 1984
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.Proceedings of the National Academy of Sciences, 1983
- 9-(1,3-Dihydroxy-2-propoxymethyl)guanine: a new potent and selective antiherpes agentJournal of Medicinal Chemistry, 1983
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Cytomegalovirus Infections Following Renal TransplantationClinical Infectious Diseases, 1981
- Cytomegalovirus Disease in Renal Allograft RecipientsMedicine, 1980
- Infectious Complications of Human Bone Marrow TransplantationMedicine, 1979